Efficacy and Safety of First-Line Therapies in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis

K Haeussler, X Wang, KB Winfree, Y D'yachkova… - Future …, 2022 - Taylor & Francis
Aim: To evaluate the comparative efficacy and safety of identified first-line therapies for
patients with EGFR mutation-positive (EGFR m+) advanced non-small-cell lung cancer …
被引用次数：5 相关文章

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis.

K Haeussler, X Wang, KB Winfree… - Future Oncology …, 2022 - europepmc.org
Aim: To evaluate the comparative efficacy and safety of identified first-line therapies for
patients with EGFR mutation-positive (EGFRm+) advanced non-small-cell lung cancer …
[PDF] academia.edu

[PDF][PDF] Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

K Haeussler, X Wang, KB Winfree, Y D'yachkova… - 2022 - academia.edu
Aim: To evaluate the comparative efficacy and safety of identified first-line therapies for
patients with EGFR mutation-positive advanced non-small-cell lung cancer (NSCLC), with a …

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

K Haeussler, X Wang, K Winfree… - Future …, 2022 - research-information.bris.ac.uk
Aim: To evaluate the comparative efficacy and safety of identified first-line therapies for
patients with EGFR mutation-positive (EGFRm+) advanced non-small-cell lung cancer …

Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

K Haeussler, X Wang, KB Winfree… - Future oncology …, 2022 - pubmed.ncbi.nlm.nih.gov
Aim: To evaluate the comparative efficacy and safety of identified first-line therapies for
patients with EGFR mutation-positive (EGFRm+) advanced non-small-cell lung cancer …
[PDF] bris.ac.uk

[PDF][PDF] Efficacy and safety of first-line therapies in EGFR-mutated advanced non-small-cell lung cancer: a network meta-analysis

K Haeussler, X Wang, KB Winfree, Y D'yachkova… - 2022 - research-information.bris.ac.uk
Aim: To evaluate the comparative efficacy and safety of identified first-line therapies for
patients with EGFR mutation-positive (EGFRm+) advanced non-small-cell lung cancer …